| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Decade of Advances in Cytotoxic Chemotherapy for Metastatic Colorectal Cancer
|
Lucas, Amy S.
|
|
2011
|
10 |
4 |
p. 238-244
7 p.
|
artikel
|
| 2 |
A Decade of Clinical Colorectal Cancer
|
Chu, Edward
|
|
2011
|
10 |
4 |
p. 217-
1 p.
|
artikel
|
| 3 |
Analysis for Prognostic Factors of 60-day Mortality: Evaluation of an Irinotecan-Based Phase III Trial Performed in the First-Line Treatment of Metastatic Colorectal Cancer
|
Giessen, Clemens
|
|
2011
|
10 |
4 |
p. 317-324
8 p.
|
artikel
|
| 4 |
Colorectal Chemoprevention Pilot Study (SWOG-9041), Randomized and Placebo Controlled: The Importance of Multiple Luminal Lesions
|
Chu, David Z.J.
|
|
2011
|
10 |
4 |
p. 310-316
7 p.
|
artikel
|
| 5 |
Development of Molecular Biomarkers in Individualized Treatment of Colorectal Cancer
|
De Mattos-Arruda, Leticia
|
|
2011
|
10 |
4 |
p. 279-289
11 p.
|
artikel
|
| 6 |
Development of Novel Targeted Agents in the Treatment of Metastatic Colorectal Cancer
|
Berge, Eamon
|
|
2011
|
10 |
4 |
p. 266-278
13 p.
|
artikel
|
| 7 |
Editorial Board
|
|
|
2011
|
10 |
4 |
p. A1-
1 p.
|
artikel
|
| 8 |
Emerging Therapies for Advanced Gastroenteropancreatic Neuroendocrine Tumors
|
Gupta, Sameer
|
|
2011
|
10 |
4 |
p. 298-309
12 p.
|
artikel
|
| 9 |
Integration of Biologic Agents With Cytotoxic Chemotherapy in Metastatic Colorectal Cancer
|
Jain, Vikram K.
|
|
2011
|
10 |
4 |
p. 245-257
13 p.
|
artikel
|
| 10 |
Is There a Role for IGF1R and c-MET Pathways in Resistance to Cetuximab in Metastatic Colorectal Cancer?
|
Inno, Alessandro
|
|
2011
|
10 |
4 |
p. 325-332
8 p.
|
artikel
|
| 11 |
Nonoperative Approach to Locally Advanced Rectal Cancer After Neoadjuvant Combined Modality Therapy: Challenges and Opportunities From a Surgical Perspective
|
Fischkoff, Katherine N.
|
|
2011
|
10 |
4 |
p. 291-297
7 p.
|
artikel
|
| 12 |
Philanthropy, Advocacy and Colon Cancer
|
Marshall, John L.
|
|
2011
|
10 |
4 |
p. 290-
1 p.
|
artikel
|
| 13 |
Prognostic Significance of miR-215 in Colon Cancer
|
Karaayvaz, Mihriban
|
|
2011
|
10 |
4 |
p. 340-347
8 p.
|
artikel
|
| 14 |
Progress in the Treatment of Locally Advanced Clinically Resectable Rectal Cancer
|
Minsky, Bruce D.
|
|
2011
|
10 |
4 |
p. 227-237
11 p.
|
artikel
|
| 15 |
Successful Twin Pregnancy Outcome After In Utero Exposure to FOLFOX for Metastatic Colon Cancer: A Case Report and Review of the Literature
|
Jeppesen, Johanne Bakker
|
|
2011
|
10 |
4 |
p. 348-352
5 p.
|
artikel
|
| 16 |
Table of Contents
|
|
|
2011
|
10 |
4 |
p. A6-A7
nvt p.
|
artikel
|
| 17 |
The Efficacy and Safety of Panitumumab Administered Concomitantly With FOLFIRI or Irinotecan in Second-Line Therapy for Metastatic Colorectal Cancer: The Secondary Analysis From STEPP (Skin Toxicity Evaluation Protocol With Panitumumab) by KRAS Status
|
Mitchell, Edith P.
|
|
2011
|
10 |
4 |
p. 333-339
7 p.
|
artikel
|
| 18 |
The Evolution of Adjuvant Therapy in the Treatment of Early-Stage Colon Cancer
|
de Gramont, Aimery
|
|
2011
|
10 |
4 |
p. 218-226
9 p.
|
artikel
|
| 19 |
Treatment Advances in Liver-Limited Metastatic Colorectal Cancer
|
Alberts, Steven R.
|
|
2011
|
10 |
4 |
p. 258-265
8 p.
|
artikel
|
Tijdschrift beschrijving